Thursday, 30 May 2013

08:00

Registration

09:20

Inauguration

09:30

Yogender GuptaKeynote Presentation

Regulations and Development in Safety Assessment of New Drugs in India
Yogender Gupta, Professor, All India Institute of Medical Sciences, India

10:15

Coffee Break and Networking in Exhibition Hall

10:35

Jyoti PaliwalKeynote Presentation

All About ADME: Why, When, Where and How Much?
Jyoti Paliwal, Medical Advisor, Troikaa Pharmaceuticals Limited , India

11:15

Challenges in ADME and Metabolomics
Girish Jain, Scientist F, Central Drug Research Institute, India

11:45

Roadmaps to Success in Novel Drug Discovery and Development through PADMET Profiling
Pratima Srivastava, Associate Director, Gvk Biosciences Private Limited, India

12:15

Recent Trends in Development on LCMS/MS Enabling Unique Workflow in Metabolite Identification
Umesh Pawa, Managing Director, AB Sciex, United Arab Emirates

12:45

Lunch in the Hall

13:45

Advanced Chemistry Development IncTechnology Spotlight:
An Integrated Approach to Quick Lead Optimization Including Physiochemical and ADME Profiling
K K Bhagchandani, Director, Advanced Chemistry Development Inc

14:00

ADME, Dissolution and Bioavailability: Establishing a Relationship
Manoj Karwa, Project Manager, Auriga Research Ltd, India

14:30

Bhupinder Singh BhoopKeynote Presentation

From Biostudies to Biowaivers using IVIVC
Bhupinder Singh Bhoop, Dean, UIPS, Panjab University, India

15:10

Coffee Break and Networking in Exhibition Hall

15:30

Preclinical Formulations for Early Discovery Invivo studies
Deepak Barot, President & CEO, PBR Private Limited, India

16:30

Atrovastatin Causing Peripheral Neuropathy - Is It a Signal?
Harmeet Rehan, Professor & Head, Lady Hardinge Medical College, India

17:00

End of the Day

18:00

Drink Reception and Networking

Friday, 31 May 2013

09:00

Matthew SegallKeynote Presentation

Multi-parameter Optimization in Drug Discovery: Quickly Targeting Compounds with a Good Balance of Properties
Matthew Segall, Chief Executive Officer, Optibrium Ltd, United Kingdom

09:40

Integrating In Vitro and In Silico Approaches for Mechanistic Toxicology
Sonali Das, Director, Strand Life Sciences Pvt Ltd, India

10:10

Coffee Break and Networking in Exhibition Hall

10:30

Therapeutic Drug Monitoring and Drug Safety
Kamal Kishore, Professor, All India Institute of Medical Sciences, India

11:00

Newer Strategies in Drug Safety Research: A Translational Approach
Kavita Gulati, Associate Professor in Pharmacology, Vallabhbhai Patel Chest Institute, India

11:30

Recent Amendments to the Indian Clinical Trial Regulations and its Impact on the Clinical Research Industry
Bobby George, Vice President & Head Regulatory Affairs, Reliance Life Sciences Pvt Ltd, India

12:00

Bioavailability and Bioequivalence Pharmacokinetic Studies: An FDA Regulatory Overview
Shiva Nanjundappa, Head, Jubliant Clinsys Ltd, India


12:30

Issues and Challenges in Clinical Pharmacokinetic Evaluation of a New Drug Molecule
Samir Malhotra, Professor, PGIMER, India

13:00

Poster Session

13:20

Lunch in the Hall

14:20

Personalized Medicine: The Leading Edge in Human Health
Ritushree Kukreti, Scientist, Institute of Genomics and Integrative Biology, India

14:50

Genotoxicity Testing in Drug Safety Evaluation: Models, Bioassays and End-points for Regulatory Consideration
G Jena, Assistant Professor, National Institute of Pharmaceutical Education and Research, India

15:20

Coffee Break and Networking in Exhibition Hall

15:40

Preclinical Evaluation of Drug Safety
Arunabha Ray, Professor/Head, University of Delhi, India

16:10

Bioinformatics Concept, Methods & Techniques for ADME, Toxicology & Drug Designing
Vivek Keshri, Research Associate, National Bureau of Agriculturally Important Microorganisms, India

16:30

Panel Discussion: Pre-clinical and Clinical Outsourcing- Current Indian Scenario

17:00

End of the Conference